Improvement of Insulin Resistance With Traditional Chinese Treatment in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of Traditional Chinese Treatment(TCT)
on insulin sensitivity and other related factors in type 2 diabetes by using an double-blind,
randomized, parallel control and prospective study This traditional compound Chinese herb
preparation is referred to this study, with three kinds of plants: 50 mg of Coptis Chinensis,
30 mg of Astragalus mambranesceus and 120 mg of Lonicera Japonica, all of which are selected
by The Chinese Academy of Medical Sciences among those traditionally considered effective and
safe in the treatment of diabetes.
Patients enrolled were randomized into TCT group and placebo group administrated with TCT and
placebo respectively. Glucose disposal rate (GDR), fasting plasma glucose (FPG), postprandial
plasma glucose (PPG), HbA1C and other metabolic components were assessed at baseline and end
point